Healionics’ Vascular Access Device Featured at American Society of Nephrology’s Kidney Week 2016

Healionics’ STARport HD, a novel preclinical stage implantable device that allows needle-free bloodstream access for hemodialysis treatment, has been selected by the American Society of Nephrology (ASN) to be featured at the ASN exhibit booth at Kidney Week 2016 as one of several new technologies portraying the future of kidney disease treatment.

Kidney Week 2016 is the 50th annual kidney research meeting for ASN. This year’s meeting, November 15-20 in Chicago, IL, is expected to have approximately 13,000 attendees.

About Healionics Corporation
Healionics develops and manufactures synthetic biomaterials and implantable medical devices that offer reduced foreign body reaction, fibrotic encapsulation and infection risk. The precisely controlled pore structure of Healionics’ innovative STAR® technology induces a favorable healing response and improves tissue integration resulting in enhanced performance and longevity of implantable devices. This patented technology is currently available as an implant for glaucoma treatment and has shown promising preclinical results in other implantable devices and applications.

About American Society of Nephrology
ASN leads the fight to prevent, treat, and cure kidney diseases throughout the world by educating health professionals and scientists, advancing research and innovation, communicating new knowledge, and advocating for the highest quality care for patients.